Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06217783 · ClinicalTrials.gov registry record · NA
Ultrasound-guided Peripheral Intravenous Catheter Placement in an Oncologic Emergency Department - a Prospective, Randomized Controlled Trial of Catheter Lengths
A NA study of Oncologic Complications and Emergencies, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT06217783 is a NA study of Oncologic Complications and Emergencies that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 400 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06217783, a NA study of Oncologic Complications and Emergencies, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
To learn about the effects of the length of the catheter on the failure and success rate of USIV placement.
Conditions Studied
Interventions
- DEVICE Introcan Safety IV Catheter
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2024-03-27 |
| Est. Completion | 2027-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06217783
The ClinicalTrials.gov registry entry for NCT06217783 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Oncologic Complications and Emergencies appearing as the primary indexed condition, and to 1 intervention - of which Introcan Safety IV Catheter is the first listed.
NCT06217783 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06217783 about?
NCT06217783 is a clinical study titled "Ultrasound-guided Peripheral Intravenous Catheter Placement in an Oncologic Emergency Department - a Prospective, Randomized Controlled Trial of Catheter Lengths". To learn about the effects of the length of the catheter on the failure and success rate of USIV placement.
What is the current status of trial NCT06217783?
This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2024-03-27. Estimated completion is 2027-12-01.
What conditions does trial NCT06217783 study?
This clinical trial studies the following conditions: Oncologic Complications and Emergencies.
What interventions are being tested in trial NCT06217783?
The interventions under investigation include: Introcan Safety IV Catheter (DEVICE).
Who is sponsoring clinical trial NCT06217783?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06217783 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.